ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $618M

      Shares

      5.47M

      % of Portfolio

      0.53%

      Average Buy Price

      $74.8

      Avg closing price
      Price range

      48 Ken Griffin Gilead Sciences Trades

      Ken Griffin acquired 5.47M Gilead Sciences shares worth $618M. That's 0.53% of their equity portfolio (20th largest holding). The first Gilead Sciences trade was made in Q2 2013. Since then Ken Griffin bought shares 60 more times and sold shares on 57 occasions. The stake costed the investor $409M, netting the investor a gain of 51% so far.

      Avg closing price
      Price range
      Increased shares by 1.8% (+96.6k shares) Q2 2025
      Avg closing price $106.47
      Price range $96.91 - $113.00
      Increased shares by 14.4% (+678k shares) Q1 2025
      Avg closing price $102.80
      Price range $89.14 - $117.41
      Sold 6.4% shares (-322k shares) Q4 2024
      Avg closing price $90.22
      Price range $83.94 - $97.90
      Increased shares by 1702.5% (+4.74M shares) Q3 2024
      Avg closing price $76.20
      Price range $66.59 - $83.99
      Sold 94.8% shares (-5.04M shares) Q2 2024
      Avg closing price $66.73
      Price range $63.15 - $72.88
      Increased shares by 1226.4% (+4.92M shares) Q1 2024
      Avg closing price $76.90
      Price range $71.58 - $87.29
      Increased shares by 2.4% (+9.29k shares) Q4 2023
      Avg closing price $77.82
      Price range $73.27 - $83.09
      Increased shares by 31.1% (+93.1k shares) Q3 2023
      Avg closing price $76.92
      Price range $73.94 - $80.67
      Sold 86.7% shares (-1.95M shares) Q2 2023
      Avg closing price $79.75
      Price range $76.01 - $86.70
      Increased shares by 36.1% (+597k shares) Q1 2023
      Avg closing price $82.82
      Price range $77.31 - $88.08
      Increased shares by 384.7% (+1.31M shares) Q4 2022
      Avg closing price $79.19
      Price range $62.32 - $89.47
      Sold 89.1% shares (-2.79M shares) Q3 2022
      Avg closing price $63.06
      Price range $59.54 - $68.01
      Increased shares by 27.7% (+677k shares) Q2 2022
      Avg closing price $61.91
      Price range $57.72 - $65.01
      Increased shares by 268.7% (+1.79M shares) Q1 2022
      Avg closing price $63.92
      Price range $57.92 - $72.58
      Increased shares by 67.6% (+268k shares) Q4 2021
      Avg closing price $68.88
      Price range $64.88 - $73.64
      Sold 65.7% shares (-759k shares) Q3 2021
      Avg closing price $70.25
      Price range $67.69 - $73.03
      Sold 81.1% shares (-4.97M shares) Q2 2021
      Avg closing price $66.77
      Price range $63.47 - $69.35
      Increased shares by 115.7% (+3.29M shares) Q1 2021
      Avg closing price $64.48
      Price range $60.00 - $68.46
      Increased shares by 56.3% (+1.02M shares) Q3 2020
      Avg closing price $69.35
      Price range $62.10 - $78.08
      Increased shares by 223.8% (+1.26M shares) Q2 2020
      Avg closing price $76.64
      Price range $72.34 - $84.00

      News about Gilead Sciences, Inc. and Ken Griffin

      History''s worst secretary of defense: Rumsfeld''s death leaves behind a legacy of arrogance and violence

      History''s worst secretary of defense: Rumsfeld''s death leaves behind a legacy of arrogance and violence

      Rumsfeld''s upbringing isn''t really very interesting ; upper-middle class German-American family from Illinois, Boy Scouts, Princeton, ROTC, marriage at 22,...

      AlterNet AlterNet, about 4 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×